Gastrointestinal Agents : Digestants
OMOPR2“MoProbi-LR capsule”150 mg/cap”
適應症：緩解輕度腹瀉、腹痛及便秘、整腸(調整排便)，軟便。
Usual dose:
Adult (≧12 yrs): PO 1 Cap tid-qid or prn
Adverse effect:
Common: flatulence.
Related Entries
(Visited 114 times, 1 visits today)
登入仁醫心法
搜尋仁醫の藥書
分類
- Archeology (內專試題考古題)
- Cardiology (心臟科)
- Case Record ( 病例討論)
- Critical Care Medicine (重症醫學)
- Endocrinology (新陳代謝/內分泌科)
- Gastroenterology (肝膽腸胃科)
- Guideline
- Hematology/Oncology (血液腫瘤科)
- Infectious Diseases (感染科)
- Lectures (教學)
- Nephrology (腎臟科)
- Neurology (神經內科)
- Others (其他科別)
- Pulmonary Medicine (胸腔科)
- Renal Biopsy ( 腎臟切片）
- Review (品評文獻)
- Rheumatology (風濕免疫科)
標籤
ACEI
ADA
allopurinol
antibiotics
aortic dissection
ARB
arrhythmia
atrial fibrillation
bisoprolol
cardiovascular disease
carvedilol
Clinical Practice Guideline for the Management of Glomerular Diseases
Crohn's disease
dapagliflozin
diabetes mellitus
DPP-4
ENaC
fatty liver
febuxostat
GLP-1
gout
HbA1c
heart failure
hyperkalemia
hypertension
hypoglycemia
ICH
inflammatory bowel disease
insulin
KDIGO，GN，Glomerulonephritis
Lantus
metformin
myasthenia gravis
obstructive sleep apnea
pneumonia
pyoderma gangrenosum
seizure
SGLT-2
stroke
sulfonylurea
thiozolidinedione
thymoma
Toujeo
vedolizumab
內專甄審